Cargando…
Direct Costs of Opioid Abuse in an Insured Population in the United States
OBJECTIVE: To (a) describe the demographics of opioid abusers; (b) compare the prevalence rates of selected comorbidities and the medical and drug utilization patterns of opioid abusers with patients from a control group, for the period from 1998 to 2002; and (c) calculate the mean annual per-patien...
Autores principales: | WHITE, ALAN G., BIRNBAUM, HOWARD G., MAREVA, MILENA N., DAHER, MAHAM, VALLOW, SUSAN, SCHEIN, JEFF, KATZ, NATHANIEL |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391027/ https://www.ncbi.nlm.nih.gov/pubmed/32996392 http://dx.doi.org/10.18553/jmcp.2020.26.10.1188 |
Ejemplares similares
-
Direct Costs of Opioid Abuse in an Insured Population in the United States
por: White, Alan G., et al.
Publicado: (2005) -
Framework for Pharmacy Services Quality Improvement—A Bridge to Cross the Quality Chasm: Part I. The Opportunity and the Tool
por: CURTISS, FREDERIC R., et al.
Publicado: (2020) -
Effects of a 3-Tier Pharmacy Benefit Design on the Prescription Purchasing Behavior of Individuals With Chronic Disease
por: NAIR, KAVITA V., et al.
Publicado: (2020) -
Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System
por: de Oliveira, Djenane Ramalho, et al.
Publicado: (2020) -
Are ACOs Ready to be Accountable for Medication Use?
por: Dubois, Robert W., et al.
Publicado: (2020)